The Board of Pharmacy’s rules, permitting pharmacists to provide patients 18 years of age and older with self-administered hormonal contraceptives via a standing order, were approved and effective immediately. The Arizona Department of Health Services issued the statewide standing order.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy posted the new OTC Naloxone FAQ on its website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy’s emergency rule permitting a pharmacist to delegate the administration of a vaccine to a trained pharmacy technician while under the supervision of the pharmacist was published with an effective date of May 4, 2023, in the “Arizona Administrative Register”; see pages 1196 through 1201. Also, note the inclusion of special continuing education requirements for technicians administering vaccines.
Also in Arizona, NACDS submitted comment letters to the Board of Pharmacy in support of the following proposed rules:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
On May 3, Kristin K. Mayes, Attorney General, added her signature to the Board of Pharmacy’s emergency rules allowing a pharmacy technician to administer a vaccine when the technician has completed specified training and the authority to administer the vaccine is delegated by and under the supervision of the pharmacist on duty. The rule will be effective when filed with the Office of the Secretary of State.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
On April 18, Gov. Katie Hobbs (D) signed SB (Senate Bill) 1382 (Chapter 74), legislation requiring PBMs to obtain a certificate of authority to operate and outlining the role, responsibilities and authority of the Department of Insurance and Financial Institutions.
Also in Arizona, the Board of Pharmacy scheduled Oral Proceeding/Public Comment RE: Prescribing a Self-Administered Hormonal Contraceptive on May 16 from 9:00 a.m.-10:00 a.m.
Finally in Arizona, the Board of Pharmacy Oral Proceeding/Public Comment RE: Technician Immunization Authority on May 22 at 9:00 a.m.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
SB 1283, legislation requiring PBMs to obtain a certificate of authority to operate and outlining the role, responsibilities and authority of the Department of Insurance and Financial Institutions, was heard in the House Regulatory Affairs Committee on March 22 where is was amended and voted (6-1) with “Do Pass Amended”.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Gov. Katie Hobbs (D) vetoed SB (Senate Bill) 1248, legislation repealing several components of the sunrise process for scope expansion, including pharmacy.
Also in Arizona, on March 6, SB 1254 (Senate Engrossed), legislation repealing the requirement for a Schedule II opioid prescription that is directly dispensed by a pharmacist and that is not for the immediate administration to the ultimate user to have a red cap, failed to pass the House Health and Human Services Committee by a 3-4 vote.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
SB 1248, legislation repealing several components of the sunrise process for scope expansion, including pharmacy, passed the Senate (21-9) and the House (42-18) and was sent to the Gov. Katie Hobbs (D) for signature. The sunrise process will require material changes to certification, registration, or licensure.
Also in Arizona, on February 20, SB 1254 (Senate Engrossed), legislation repealing the requirement for a Schedule II opioid prescription that is directly dispensed by a pharmacist and that is not for the immediate administration to the ultimate user to have a red cap, passed the Senate and was transmitted to the House.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy Task Force Committee-Rules Writing meeting will be held on February 22 at 9:00 a.m. An agenda has not been posted on the website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.